adenosine diphosphate has been researched along with tak 029 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, JC; Coller, BS; Hillman, RS; Lee, TT; Lincoff, AM; Smith, JW; Steinhubl, SR | 1 |
| Abe, T; Fukuuchi, Y; Inoue, K; Satoh, H; Tanahashi, N; Tomita, M; Tomita, Y | 1 |
2 other study(ies) available for adenosine diphosphate and tak 029
| Article | Year |
|---|---|
Rapid platelet-function assay: an automated and quantitative cartridge-based method.
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; Autoanalysis; Guanidines; Humans; Immunoglobulin Fab Fragments; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines; Radiometry; Time Factors | 1999 |
Adhesion of adenosine diphosphate-activated platelets to human brain microvascular endothelial cells under flow in vitro is mediated via GPIIb/IIIa.
Topics: Adenosine Diphosphate; Brain; Cells, Cultured; Endothelium, Vascular; Fibrinolytic Agents; Guanidines; Humans; Microcirculation; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines | 2001 |